Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2007
10/24/2007CN101057906A Traditional Chinese medicinal composition for treating hepatitis and its preparation method and medicinal preparation
10/24/2007CN101057902A Medicine and its quality control method
10/24/2007CN101057901A Traditional Chinese medicinal composition for curing hepatitis
10/24/2007CN101057896A Traditional Chinese medicinal embrocation for treating psoriasis
10/24/2007CN101057888A Traditional Chinese medicinal composition for regulating immunity and its preparation method and application
10/24/2007CN101057879A Microwave extraction method for total flavones of sacandra glabra
10/24/2007CN101057878A Pomegranate rind extraction and its preparation method
10/24/2007CN101057873A Method for preparing hepatitis B virus resisting maggot protein powder and its maggot oil and fatty acid
10/24/2007CN101057866A Method for preparing 'kelike' capsule
10/24/2007CN101057865A Method for preparing 'youkadan' granule
10/24/2007CN101057864A Technology for preparing anti influenza virus transfer factors
10/24/2007CN101057858A Protecting agent for preventing and curing cow and goat mastitis and its preparation method
10/24/2007CN101057853A Antiadhesive carbohydrates
10/24/2007CN101057851A Improved entecavir effervescent tablet and its preparation method
10/24/2007CN101057844A Chrisma for vaginal containing tioconzole and its preparation method
10/24/2007CN101057843A External applied spraying agent with tioconazole and its preparation method
10/24/2007CN101057841A 'Yanhuning' frozen-dried powder injection and its preparation method
10/24/2007CN101057617A Green bean tea for treating influenza
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344626C Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives
10/24/2007CN100344331C Targeted small interference RNA formulation for preventing and treating Hepatitis C and its preparation method
10/24/2007CN100344330C Targeted small interference RNA formulation for treating viral Hepatitis B and its preparation
10/24/2007CN100344327C Vaccine for reticuloendothliosis of poultry and preparing method thereof
10/24/2007CN100344324C Cream of liposome of interferon
10/24/2007CN100344310C Medicine for treating tinea containing biological alkaline salt and preparation thereof
10/24/2007CN100344300C Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method
10/24/2007CN100344296C Chimonanthus nitense leaf drop pills for preventing common cold and preparation technique thereof
10/24/2007CN100344284C Use of Abidol in preparing medicines for treating and preventing SARS virus
10/24/2007CN100344283C Abidor inclusion compound
10/24/2007CN100344282C Method for preparing rifamicina injecta
10/24/2007CN100344234C Pesticidal formulation
10/23/2007USRE39892 Pessaries or vaginal tablets of two layers of lactobacilli brevis and salivarius, in bound form, so that the release velocity of bacteria of the outermost layer is greater than the release velocity of bacteria of the innermost layer.
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285676 Synthesis of chiral 2-alkyl amino acids
10/23/2007US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used
10/23/2007US7285668 At a concentration of 0.1-0.5 g/ml. at 0-35 degrees C. from a C1-4 alkyl acetate solution; preservation stability
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285661 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
10/23/2007US7285660 Process for the preparation of L-ribavirin
10/23/2007US7285659 Process for the preparation of D-ribavirin
10/23/2007US7285658 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions
10/23/2007US7285619 E.g, 1-([-4-oxo-N2-(12-methyl-1-oxotetradecyl)-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B and 1-[N2-[[4'-octyloxy)-[1,1'-biphenyl]-4-yl]-carbonyl]-4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285558 Helicobacter infections; bactericides
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285552 For prevention and/or treatment for HIV infection or AIDS induced by the infection
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285539 Using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides and polynucleotides encoding them
10/23/2007US7285517 Warming and nonirritating lubricant compositions and method of comparing irritation
10/23/2007US7285389 Protein, gene encoding the same, and method of utilization thereof
10/23/2007US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/23/2007US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007CA2406849C Stabilized liquid preparation
10/23/2007CA2350905C Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
10/23/2007CA2340156C .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/23/2007CA2217780C Polyether nucleic acids
10/23/2007CA2142981C Vaccines against group c neisseria meningitidis
10/23/2007CA2086258C Pasteurella multocida toxoid vaccines
10/18/2007WO2007117715A2 Modulators of atp-binding cassette transporters
10/18/2007WO2007117241A1 Intramuscular antiviral treatments
10/18/2007WO2007116960A1 Oxazolidinone derivative having carbocyclic ring
10/18/2007WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007115947A1 Pyrrolo-quinoxalinone derivatives as antibacterials
10/18/2007WO2007115820A1 Chromen-2-one derivatives
10/18/2007WO2007115635A1 Biguanide-containing liposomes
10/18/2007WO2007034166A8 Adjuvanted vaccine
10/18/2007WO2006087544A8 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007US20070244186 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
10/18/2007US20070244160 6-11 Bicyclic Ketolide Derivatives
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244103 Novel Compounds Having an Anti-Bacterial Activity
10/18/2007US20070244091 treating bacterial infections; 6-({[(1-{2-[3-Fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azetidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin or oxazin-3(4H)-one; antibiotics; grampositive Staphylococcus, gramnegative Haemophilus, Moraxella, Escherichia
10/18/2007US20070244081 Triterpene quaternary salts as biologically active surfactants
10/18/2007US20070244059 Method For Attentuating Virulence Of Microbial Pathogens And For Inhibiting Microbial Biofilm Formation
10/18/2007US20070244052 Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same
10/18/2007US20070244044 Antimicrobial Peptides
10/18/2007US20070243629 High Affinity Ligands for Influenza Virus and Methods for Their Production
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007US20070243222 Fungicidal formulation and method of use
10/18/2007US20070243200 Trehalose producing cells as vaccines
10/18/2007US20070243166 Hepatitis C Inhibitor Compounds
10/18/2007US20070243162 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis
10/18/2007CA2853611A1 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007CA2649090A1 Intramuscular antiviral treatments
10/18/2007CA2648719A1 Modulators of atp-binding cassette transporters
10/18/2007CA2647448A1 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007CA2645547A1 Biguanide-containing liposomes
10/18/2007CA2644951A1 Chromen-2-one derivatives
10/18/2007CA2634465A1 Development of novel antibiotic alternatives
10/17/2007EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/17/2007EP1845083A2 New arylsulfonohydrazide inhibitors of enzymes MurC and MurD
10/17/2007EP1844791A1 Improved modified live BRSV vaccine
10/17/2007EP1844776A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
10/17/2007EP1844775A1 Therapeutic agent for herpes progenitalis
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 1798